Introducing competing "biosimilar" versions of complex biologic drugs used to treat illnesses such as cancer and rheumatoid arthritis could cut spending on biologics in the United States by $44 billion over the next decade, ...
Nov 3, 2014
0
0
Can pain relievers really target a specific part of the body? Are generic medicines inferior to their brand-name counterparts? Are natural medicines always safer then prescription drugs? Can you mix alcohol with a prescription ...
Oct 13, 2014
0
0
Gilead Sciences has reached a deal with several generic drugmakers to produce a cheaper version of its popular, $1,000-per-pill hepatitis C drug Sovaldi for use in developing countries.
Sep 15, 2014
0
0
Generic versions of the same prescription drug are clinically interchangeable but often look different depending on the manufacturer. The FDA does not require consistent pill appearance among interchangeable generic drugs, ...
Jul 14, 2014
0
0
(HealthDay)—The U.S. Food and Drug Administration on Friday gave its approval to the first generic version of the pain reliever Celebrex (celecoxib).
Jun 3, 2014
0
0
Dermatologists with access to free drug samples are more likely than those without access to samples to write prescriptions for drugs that are more expensive, according to a study by researchers at the Stanford University ...
Apr 16, 2014
0
0
The Supreme Court is wading into a patent dispute between rival pharmaceutical companies over a multiple sclerosis treatment.
Mar 31, 2014
0
0
Although there is widespread consensus among the scientific community that the composition of generic drugs is identical to that of brand name drugs, this is not the case among the public. In a four-year study of over 3,000 ...
Mar 6, 2014
0
0
Drugmaker Pfizer said Tuesday that fourth-quarter profit plunged 59 percent because of discontinued operations, restructuring and other charges, and generic competition continuing to siphon off revenue from former blockbuster ...
Jan 28, 2014
0
0
Teva Pharmaceutical Industries, the world's largest maker of generic drugs, said Thursday it had appointed a new chief executive to replace Jeremy Levin, who left abruptly in October.
Jan 9, 2014
0
0
